Inicio・Lista de Acciones・Ocugen Inc

Ocugen Inc

Abierto

1.28

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.24

Máximo

1.28

Métricas clave
By Trading Economics
Ingresos	-1.5M -19M
Ventas	1.7M 1.5M
BPA	-0.06
Margen de beneficios	-1,250.946
Empleados	116
EBITDA	-987K -17M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+673.6% upside

Dividendos
By Acuity
Próximas Ganancias	6 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-200M 427M
Apertura anterior	1.28
Cierre anterior	1.28

Ocugen Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 ago 2026, 23:56 UTC

Full Truck Alliance Co Ltd. is trading higher in after-market hours, reflecting routine fluctuations within a narrow range above its 20-day moving average.

3 ago 2026, 23:56 UTC

State Street Corp shares are trading lower in after-market hours, following a modest decline after Monday's regular session close.

3 ago 2026, 23:56 UTC

Pentair PLC shares are lower in after-market hours with no specific news driving the decline. The stock remains within its one-month trading range.

3 ago 2026, 23:56 UTC

News

Diversified Healthcare Trust reported second-quarter FFO of $0.16, exceeding estimates. Revenue fell short at $365.39 million, contributing to a decline in after-market trading.

3 ago 2026, 23:56 UTC

Correlated Moves

Masco Corp shares are higher in after-market trading, supported by a notable rise in JELD-WEN Holding Inc. The stock remains near its one-month range low.

3 ago 2026, 23:56 UTC

Stanley Black & Decker shares are higher in after-market trading, supported by positive market sentiment and easing inflation concerns amid declining oil prices.

3 ago 2026, 23:56 UTC

Correlated Moves

Microstrategy Inc shares declined after market hours, reaching a low of -1.10%. The drop may be influenced by Bitcoin's recent decline.

3 ago 2026, 23:56 UTC

Chewy Inc. shares are trading higher in after-market hours, rebounding from a brief dip following Monday's close amid broader positive market sentiment.

3 ago 2026, 23:56 UTC

Kroger Co shares are lower in after-market trading, retracing from an earlier rise and settling around the midpoint of their one-month trading range.

3 ago 2026, 23:56 UTC

MGM Resorts International shares are higher in after-market hours, continuing modest gains since Monday's close amid positive sentiment in European markets.

3 ago 2026, 23:56 UTC

Equinix Inc shares are higher in after-market hours, reflecting broader market strength amid gains in European indices and falling oil prices.

3 ago 2026, 23:56 UTC

Correlated Moves

Martin Marietta Materials shares are higher in after-market trading, supported by positive market sentiment and correlated gains in nVent Electric PLC.

3 ago 2026, 23:56 UTC

Incyte Corp shares are higher in after-market hours, recovering from five consecutive daily declines. Broader market sentiment remains positive amid declining oil prices.

3 ago 2026, 23:56 UTC

Brown & Brown Inc shares are trading lower in after-market hours, following a session that included an early spike before a steady decline.

3 ago 2026, 23:56 UTC

AutoZone Inc shares are trading higher in after-market hours, recovering from a dip after Monday's close with no specific news identified for the movement.

3 ago 2026, 23:56 UTC

J M Smucker Co shares are higher in after-market hours, recovering from earlier declines and remaining above their 20-day moving average. No specific news was identified.

3 ago 2026, 23:56 UTC

ETF Constituents

The iShares China Large-Cap ETF is trading roughly flat in after-market hours, supported by LI's positive return and JD's slight decline.

3 ago 2026, 23:56 UTC

Correlated Moves

NIO Inc shares are higher in after-market trading, reflecting positive sentiment in the electric vehicle sector. Xpeng Inc also saw a price increase.

3 ago 2026, 23:56 UTC

JPMorgan Chase & Co shares are higher in after-market hours, supported by positive sentiment in European markets. The asset remains above its 20-day moving average.

3 ago 2026, 23:56 UTC

Bath & Body Works Inc. shares declined slightly in after-market trading, reflecting routine fluctuations despite remaining above the 20-day moving average.

3 ago 2026, 23:56 UTC

News

First Solar Inc reported second-quarter revenue of $1.06 billion and a net profit of $423 million. Shares are higher in after-hours trading.

3 ago 2026, 23:56 UTC

Cisco Systems Inc shares are lower in after-market hours, with no specific news identified to explain the decline. The broader market showed mixed signals.

3 ago 2026, 23:56 UTC

Indie Semiconductor Inc. shares are higher in after-market trading, showing modest gains since Monday's close amid positive broader market sentiment.

3 ago 2026, 23:56 UTC

Correlated Moves

Riot Platforms Inc. is higher in after-market hours, recovering from an initial dip. Positive sentiment in European indices supports cryptocurrency-related stocks.

3 ago 2026, 23:56 UTC

Correlated Moves

Kosmos Energy Ltd shares are higher in after-hours trading, reflecting positive sentiment in the energy sector and influenced by Crescent Energy's notable gains.

3 ago 2026, 23:56 UTC

New Fortress Energy Inc shares are higher in after-market trading, reflecting a recovery from earlier lows amid positive sentiment in European markets.

3 ago 2026, 23:56 UTC

Macro News

Crude oil prices are lower as President Trump called off a military strike on Iran, boosting optimism for stability in the Middle East.

3 ago 2026, 23:52 UTC

Social Media

Correlated Moves

News

Microsoft shares are lower in after-market hours amid a class action lawsuit alleging misrepresentation of its Copilot products' performance and competitive position.

3 ago 2026, 23:51 UTC

Schneider National shares higher in after-market trading, reflecting notable strength since Monday's close despite remaining below the 20-day moving average.

3 ago 2026, 23:51 UTC

Shake Shack Inc. shares declined after-market, contrasting with gains in major U.S. tech stocks. The asset remains above its 20-day moving average.

Comparación entre iguales

Cambio de precio

Ocugen Inc previsión

Precio Objetivo

By TipRanks

673.6% repunte

Estimación a 12 Meses

Media 9.67 USD 673.6%

Máximo 12 USD

Mínimo 7 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Ocugen Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

6 ratings

Comprar

Mantener

Vender

De acuerdo con 6 analistas que ofrecen calificaciones bursátiles a para Ocugen Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.